Yule Catto & Co PLC
9 May 2001
YULE CATTO & CO PLC ('YULE CATTO')
Sale of Unilock Limited ('Unilock')
Yule Catto is an international producer of speciality chemicals, which are
supplied to global customers, ranging from manufacturers of medical gloves,
paint and adhesives to the pharmaceuticals and cosmetics industries.
Yule Catto announces today the sale of Unilock to the former Divisional Chief
Executive of its Building Products Division, Clive Sanders.
Unilock is a leading supplier in the UK of office partitioning systems and has
net assets at completion of the sale of some £1.6 million.
Commenting on the transaction Alex Walker, Chief Executive of Yule Catto said:
'The sale of Unilock completes the disposal of Yule Catto's building products
businesses and achieves the realignment of the group's operations into a
company focussed upon speciality chemicals.'
9 May 2001
ENQUIRIES:
Yule Catto plc Tel: 01279 442791
Alex Walker, Chief Executive
Sean Cummins, Finance Director
College Hill Tel: 020 7457 2020
Gareth David Email: gareth.david@collegehill.com
Lisa Pearson Email: lisa.pearson@collegehill.com
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.